Tenaya Therapeutics (TNYA)
NASDAQ:TNYA
US Market
Holding TNYA?
Track your performance easily

Tenaya Therapeutics (TNYA) Financial Statements

432 Followers

Tenaya Therapeutics Financial Overview

Tenaya Therapeutics's market cap is currently ―. The company's EPS TTM is $-1.573; its P/E ratio is -1.26; Tenaya Therapeutics is scheduled to report earnings on November 6, 2024, and the estimated EPS forecast is $-0.37. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Dec 23Sep 23Jun 23
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT$ -29.43M$ -32.23M$ -29.93M$ -29.14M$ -33.27M
EBITDA$ -26.34M$ -29.34M$ -25.26M-$ -30.79M
Net Income Common Stockholders$ -29.43M$ -32.20M$ -29.95M$ -29.14M$ -33.27M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 99.30M$ 122.25M$ 104.64M$ 121.75M$ 132.50M
Total Assets$ 163.19M$ 184.90M$ 170.51M$ 193.40M$ 220.75M
Total Debt$ 15.57M$ 11.37M$ 12.42M$ 12.04M$ 13.10M
Net Debt$ -83.73M$ -110.88M$ -92.22M$ -109.71M$ -119.40M
Total Liabilities$ 29.19M$ 26.72M$ 31.09M$ 28.51M$ 30.81M
Stockholders Equity$ 134.04M$ 158.18M$ 139.42M$ 164.88M$ 189.94M
Cash Flow-
Free Cash Flow$ -23.69M$ -29.22M$ -22.32M-$ -26.41M
Operating Cash Flow$ -23.62M$ -28.66M$ -21.92M$ -23.64M$ -26.20M
Investing Cash Flow$ 21.61M$ -4.49M$ -14.92M$ 30.49M$ 25.09M
Financing Cash Flow$ 570.00K$ 46.77M$ 371.00K-$ 4.18M
Currency in USD

Tenaya Therapeutics Earnings and Revenue History

Tenaya Therapeutics Debt to Assets

Tenaya Therapeutics Cash Flow

Tenaya Therapeutics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis